CAS: 1443437-74-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]- REF: AN-AG001JDDCAS: 1443437-74-8 | ≥98%(HPLC) | To inquire | Tue 21 May 24 |
 | CCG-203971 REF: TM-T4306CAS: 1443437-74-8 | 99.35% | To inquire | Tue 28 May 24 |
 | CCG 203971 REF: 3D-FC76600CAS: 1443437-74-8 | Min. 95% | To inquire | Mon 01 Jul 24 |
![3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-](https://static.cymitquimica.com/products/AN/thumb/AG001JDD.jpg)
3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-
CAS:1443437-74-8
Formula:
C23H21ClN2O3
Purity:
≥98%(HPLC)
Color and Shape:
Solid
Molecular weight:
408.8774
Ref: AN-AG001JDD
| 1g | To inquire | |
| 5mg | 86.00 € | |
| 10mg | 116.00 € | |
| 25mg | 172.00 € | |
| 100mg | 171.00 € | |
| 250mg | 271.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
CCG-203971
CAS:1443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: …
Formula:
C23H21ClN2O3
Purity:
99.35%
Color and Shape:
Solid
Molecular weight:
408.88
Ref: TM-T4306
| 10mg | 53.00 € | |
| 25mg | 94.00 € | |
| 50mg | 144.00 € | |
| 100mg | 224.00 € | |
| 500mg | 553.00 € | |
| 1ml*10 (DMSO) | 36.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
CCG 203971
CAS:1443437-74-8
Inhibits MRTF-SRF transcriptional pathway
Formula:
C23H21ClN2O3
Purity:
Min. 95%
Molecular weight:
408.88 g/mol
Ref: 3D-FC76600
| 10mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
